AG-825(Tyrphostin AG-825) is a potential agent for overcoming Mn-induced neurotoxicity or AD development and is a selective and ATP-competitive ErbB2 inhibitor which suppresses tyrosine phosphorylation, with an IC50 of 0.35 μM. AG825 significantly accelerates apoptosis of human neutrophils. AG-825 displays anti-cancer activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | 2-3 weeks | $ 1068 | |
200 mg | 2-3 weeks | $ 1922 | |
400 mg | 2-3 weeks | $ 3043 | |
1 g | 2-3 weeks | $ 5679 | |
2 g | 2-3 weeks | $ 8745 |
Description | AG-825(Tyrphostin AG-825) is a potential agent for overcoming Mn-induced neurotoxicity or AD development and is a selective and ATP-competitive ErbB2 inhibitor which suppresses tyrosine phosphorylation, with an IC50 of 0.35 μM. AG825 significantly accelerates apoptosis of human neutrophils. AG-825 displays anti-cancer activity. |
Targets&IC50 | EGFR: 19 μM, ErbB2: 0.35 μM |
Synonyms | Tyrphostin AG-825 |
CAS No. | 149092-50-2 |
Chemical Formula | C19H15N3O3S2 |
Molecular Weight | 397.47 |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom